In the realm of biochemical research and metabolic studies, the compound known as GC-1 peptide, formally identified as Sobetirome (GC-1), has garnered significant attention from those interested in selective receptor modulation. Known in scientific literature as 3,5-dimethyl-4[(4'-hydroxy-3'-isopropylbenzyl)-phenoxy] acetic acid, this molecule is a synthetic thyromimetic designed to interact with specific physiological pathways.
The Biochemical Nature of Sobetirome (GC-1)
When we examine the structural characteristics of this research chemical, we find that GC-1 is a high-affinity agonist at the thyroid hormone receptor Sobetirome (GC-1) | TRβ Agonist (TR) beta isoform. According to technical data from providers like Tocris, it demonstrates a binding profile with KD values of 67 pM for TRβ and 440 pM for TRα. This selectivity is crucial, as it suggests a mechanism where GC-1 can influence metabolic processes while minimizing potential off-target effects often associated with systemic thyroid hormone analogues.
Researchers often analyze how GC-1 is a thyromimetic; high affinity agonist at thyroid hormone receptor because it mimics the natural action of hormones without being a hormone itself. For those tracking research developments, it is noted that Sobetirome is a thyroid hormone receptor β specific agonist that binds selectively to TRβ-1 with an EC50 o Experimental drug turns 'bad' white fat into 'good' brown- f approximately 0.16 μM.
Exploring Metaboli by A Columbano·2017·Cited by 21—We review some of the effects ofGC-1 on different liver disorders, with reference to its possible clinical application.Read more c Mechanisms
One of the most discussed aspects in research circles is how GC-1 dramatically increases the metabolic rate. By stimulating the thyroid hormone receptor beta, the compound influences how the body processes energy. Many enthusiasts point to the idea that GC-1 drives lipid metabolism, fat burning, and thyroid-like effects without the same intensity of impact on cardiac tissue that non-selective agents might produce.
In animal models, Sobetirome increases thyroid hormone levels in animals and has been documented for its potential to assist in the conversion of white adipose tissue into metabolically active tissue. This is why many look into GC-1 on different liver disorders and the potential for lipid-lowering outcomes. Because GC-1 differentially affects plasma lipids and cardiac activity, it remains a focal point for those studying energy expenditure and substrate utilization.
Personal Perspectives and Research Observations
When engaging with the community, it is common to hear discussions regarding GC1 is a superior 3in-1 compound that some believe optimizes the balance between fat oxidation and the preservation of lean mass. While I am not a medical professional, my observatio Sobetirome (GC-1) is a thyroid hormone receptor β (TRβ)-specific agonist which bind selectively to TRβ-1 with an EC50 of 0.16 μM. n of the data suggests that the interest lies in the pr Thyroid hormone receptor beta-specific agonist GC-1 ecision of the molecule.
When sourcing such materials for research, quality is paramount. It is vital to ensure that the material is formulated and made in the USA under strict laboratory standards to ensure potency and purity. Whether you are searching for GC-1, also known as Sobetirome, or investigating its role in preclinical trials, Sobetirome - an overview the consistency of the chemical structure is what allows for reproducible results.
Safety and Technical Considerations
It is important to r 4 Nov 2024—Sobetirome, also known asGC-1, is a selective thyromimetic drug that mimics the action of thyroid hormones. It binds preferentially to the Read more eiterate that Sobetirome is a thyroxine mimetic and a high affinity agonist that should only be handled within a controlled, non-human research environment. The scientific consensus highlights that GC-1 acts as a tool to investigate the pathways of thyroid hormone receptor signaling. For those diving into the literature, understanding the difference between TRβ and TRα is essential, as the selectivity profile is what defines the utility of this peptide-like small molecule.
As research continues, the data surrounding GC-1 will undoubtedly evolve. Whether it is used for studying lipid profiles or exploring the intricacies of metabolic signaling, the focus remains on the specific, targeted modulation of the thyroid hormone receptor beta. Always prioritize high-purity sources—such as those providing de Structural basis of GC-1 selectivity for thyroid hormone tailed mass spectrometry data—to ensure that your experimental work remains accurate and reliable.
*Disclaimer: This content is for informational and research purposes only. It does not constitute medical advice or instructions for human consumption.*